Divis Lab reported a strong 26% rise in Q1FY24 consolidated net profit.

Divis Laboratories, a pharmaceutical company specializing in the manufacture of Active Pharmaceutical Ingredients (APIs) and Intermediates, released its Q1FY24 financial results, showcasing notable performance in various aspects. Here's an analysis…

Continue ReadingDivis Lab reported a strong 26% rise in Q1FY24 consolidated net profit.